Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
The results of the study indicated a strong relationship between the amount of drug used and the percentage of weight lost in the specified period of timeas the groups which received different concentrations of tirzepatide lost up to 15.7% of their body weight in comparison to those in the control group who lost 3.3% of it
Pricing, dosing, program length, medication availability, pharmacy preparation, and treatment recommendations may vary based on individual medical evaluation, provider assessment, treatment goals, and clinical appropriateness
The SURMOUNT-1 trial reported the following side effect rates among participants taking tirzepatide: Nausea: up to 20% of participants Diarrhea: approximately 16% Constipation: approximately 11% Decreased appetite: this is expected and often the desired mechanism of action Vomiting: approximately 6 to 9% Injection site reactions: mild, infrequent Most side effects peak during the first one to two weeks after each dose increase and then gradually subside as the body adapts
Important Considerations: Because it is not FDA-approved for obesity, Ozempic may be harder to access strictly for weight loss, and insurance coverage typically requires diabetes diagnosis codes
US$ 25.51
US$ 25.09
US$ 25.51
US$ 20.16
US$ 22.51
US$ 26.48
US$ 23.57
US$ 22.75
US$ 23.45
US$ 21.12
US$ 28.32
US$ 25.31
US$ 21.42
